Entering text into the input field will update the search result below

Entera Bio GAAP EPS of -$0.47 beats by $0.58, revenue of $0.57M beats by $0.03M

Mar. 08, 2022 6:44 AM ETEntera Bio Ltd. (ENTX)By: Deepa Sarvaiya, SA News Editor
  • Entera Bio press release (NASDAQ:ENTX): FY GAAP EPS of -$0.47 beats by $0.58.
  • Revenue of $0.57M (+54.1% Y/Y) beats by $0.03M.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About ENTX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Entera Bio Ltd.
Equillium, Inc.
Pieris Pharmaceuticals, Inc.
NuCana plc
Aptose Biosciences Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.